Pharmacology expert, Dr. Gobind Rai Garg has come up with a list of important 'New Drugs'. This list has been compiled keeping in mind the upcoming AIIMS-PG exam.
After going through this blog, you'll be well versed to answer any question related to this topic in the exam.
2021 Dream Pack: Clinical | Integrated | NEXT Ready
IMPORTANT DRUGS FOR AIIMS-PG
The table includes the name of the drug, mechanism, route, and indication.
Drug |
Mechanism |
Route |
Indication |
Andexanet alpha |
Bind to Factor Xa inhibitors |
Intravenous |
To reverse overdose of rivaroxaban and apixaban |
Brexanolone |
GABA-A modulator |
Intravenous |
Post partum depression |
Baloxavirmarboxil |
Inhibit viral replication by inhibiting Cap-dependent endonuclease activity of viral polymerase |
Oral |
Single dose treatment of Acute uncomplicated influenza |
Elagolix
|
GnRH antagonist |
Oral |
Pain associated with endometriosis |
Esketamine |
Non-competitive NMDA antagonist |
Intranasal |
Treatment resistant depression |
Ibalizumab |
MAb against CD4 |
Intravenous |
HIV |
Pretomanid |
Inhibit mycolic acid synthesis |
Oral |
For XDR and MDR TB (in combination with bedaquiline and linezolid) |
Pitolisant |
H3 antagonist/inverse agonist |
Oral |
Narcolepsy |
Tenapanor |
Sodium hydrogen exchanger-3 (NHE-3) inhibitor |
Oral |
IBS with constipation |
Tafenoquine |
Free radical mediated killing of hypnozoites |
Oral |
Single dose radical cure of P. vivax malaria |
Lemborexant |
Dual Orexin Antagonist (DORA)- binds to both the orexin receptors OX1R and OX2R |
Oral |
Insomnia |
Remdesivir | Remdesivir triphosphate inhibits viral RNA dependent RNA polymerase | Intravenous |
Coronavirus disease 2019 (COVID-19) |
Ubrogepant | CGRP receptor antagonist | Oral | Acute treatment of migraine with or without aura |
Rimegepant | CGRP receptor antagonist | Oral | Acute treatment of migraine with or without aura |
Lasmiditan | 5HT1F agonist | Oral | Acute treatment of migraine with or without aura |
Erenumab
|
Monoclonal antibody against CGRP receptor | SC | Migraine prophylaxis |
Galcanezumab | Monoclonal antibody against CGRP receptor | SC | Migraine prophylaxis |
Fremanezumab | Binds to CGRP ligand blocking its binding to CGRP receptor. | SC | Migraine prophylaxis |
Eptinezumab | Binds to CGRP ligand blocking its binding to CGRP receptor. | Intravenous | Migraine prophylaxis |
Romosozumab | MAB against sclerostin | SC | Osteoporosis in postmenopausal women at high risk of fracture |
To enhance your understanding, watch the video on Must Know 'New Drugs' by Dr. Gobind Rai Garg:
Good Luck!
Keep Following PrepLadder.